Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
about
The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerDirect detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivityHeparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativityTowards understanding the roles of heparan sulfate proteoglycans in Alzheimer's diseaseThe leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchorHeparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomasPHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing.Whole-Genome Sequencing of Invasion-Resistant Cells Identifies Laminin α2 as a Host Factor for Bacterial InvasionGlycomics approaches for the bioassay and structural analysis of heparin/heparan sulphatesA chemokine self-presentation mechanism involving formation of endothelial surface microstructuresPreparation of single chain variable fragment of MG(7) mAb by phage display technology.Fibroblast growth factors share binding sites in heparan sulphate.3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.Characterization of anticoagulant heparinoids by immunoprofiling.Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.Production of anti-carbohydrate antibodies by phage display technologies: potential impairment of cell growth as a result of endogenous expression.Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin.Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?Peptide-displaying phage technology in glycobiologyControl of organization and function of muscle and tendon by thrombospondin-4.Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in miceHeparan sulfate: growth control with a restricted sequence menu3-O-sulfated heparan sulfate recognized by the antibody HS4C3 contributes [corrected] to the differentiation of mouse embryonic stem cells via fas signalingThe heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Heparan sulfate proteoglycans and cancer.ScFv anti-heparan sulfate antibodies unexpectedly activate endothelial and cancer cells through p38 MAPK: implications for antibody-based targeting of heparan sulfate proteoglycans in cancer.Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation.Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate.Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell markerMapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding.Interactions between Skeletal Muscle Myoblasts and their Extracellular Matrix Revealed by a Serum Free Culture System.SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.
P2860
Q24302060-6269F0DF-5105-4783-8511-93A27A741FA1Q24328759-C8380C65-D2FA-4DBB-A8B1-9F41BB765DBCQ24631177-35D58E1C-B2B7-4EAF-9A72-63AB4887D9CDQ24673740-B5897397-2625-4964-B70A-2E11F1B5A4CEQ26992202-0C2F8CDC-A3C7-4820-8F70-4B0536F9A64FQ28201679-7B89C209-955A-4B84-ACFA-9A039B050710Q28344801-B81F90E4-B2CA-4FBA-BEB2-D2327D5EA87FQ28552108-13069339-EB3D-4D8D-866E-1AB501794FD2Q28817609-F0461FD0-8585-4556-A2A4-4191B4350A2FQ30437948-CB55D093-57F0-4981-8FA9-27C1ABB80AB6Q30540297-D4D0D9FD-FA12-4ED4-9487-6303CD2CA4CAQ30803706-35FEABFF-EF8E-4BA4-B632-BD840DD3FD04Q31153852-ECC2FAF3-1328-47DC-AD5B-B8BDF2984C76Q33230192-B3F598D9-5A1F-41E5-910B-51D37F6C9E0BQ33285352-4CFA27AE-0332-43FD-ABB8-45EA16EEE2A3Q33376879-E3AD8DF2-6604-4306-81B7-E78136D68FB8Q33581865-2B444D80-C929-4FEA-9E00-8678831AB9CFQ33644083-8FDAE070-213D-4A6A-8462-C8B09B8F5C89Q33688591-22C6D01E-C05D-465C-8B12-054B603449A1Q33824892-BA964C2B-FDF1-4149-9A22-AE6A2DA00FC7Q33932177-F986B958-747D-4B57-84B4-566C3B931115Q34022620-18CFD6A3-0133-46D4-9B83-0E95B46AA536Q34115854-7D61AC14-E9A2-44A1-A2DE-DCBDD5BF51F6Q34251345-64DB45C9-68DE-4F04-9878-DF314B2D755CQ34328757-24ADA505-73E8-4EE8-8644-C7D300A8B4DDQ34391600-10E46807-F8A2-4AC8-934E-46BB9360DBD0Q34412830-86DCC799-E138-439A-B4C6-8A5981A2A81AQ34441253-A217AA16-1D99-4784-98B6-96B91B7C475EQ34477717-BC3AF814-E5BC-4367-B9B1-CA65470F6BDAQ34509764-8F1E2C8E-8C34-4080-996D-B505BFA2DAF5Q34757062-11BC7F86-119B-4A0C-8D77-0AD3EAFE7AF1Q34774580-446D8798-5606-4631-A65D-2435A8EF70D5Q34800351-023258A3-A8E8-49C1-B28B-6E0B800FC963Q35003304-3C04C54A-4BF2-4817-91B6-9BBECBFDCECEQ35221119-E4ABC9F5-1B8B-4EE3-B820-E92506332588Q35624698-E662D6A0-9B80-4DD4-AA58-DB56FBE1E29AQ35648510-D5DE8803-F736-4E82-B3AD-51E9480862FEQ35656129-2EB9E135-CEA3-4662-84D1-EFAC3ED3E0CAQ35955763-65B57C70-9C39-4E6B-B0B0-EF6C4AD61E06Q36007478-489A5AB9-C26C-4F83-A8FA-94043A8E4BA2
P2860
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Generation and application of ...... e heterogeneity in the kidney.
@ast
Generation and application of ...... e heterogeneity in the kidney.
@en
type
label
Generation and application of ...... e heterogeneity in the kidney.
@ast
Generation and application of ...... e heterogeneity in the kidney.
@en
prefLabel
Generation and application of ...... e heterogeneity in the kidney.
@ast
Generation and application of ...... e heterogeneity in the kidney.
@en
P2093
P2860
P356
P1476
Generation and application of ...... e heterogeneity in the kidney.
@en
P2093
Dennissen MA
Veerkamp JH
van Kuppevelt TH
van Venrooij WJ
P2860
P304
12960-12966
P356
10.1074/JBC.273.21.12960
P407
P577
1998-05-01T00:00:00Z